Home

Balaxi Pharmaceuticals PE Ratio

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

PE

11.1

Last updated on: May 08, 2025

Key Highlights

  • The P/E Ratio of Balaxi Pharmaceuticals Ltd is 11.1 as of 08 May 14:27 PM .
  • The P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 12.1 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 53.25 as of 08 May 14:09 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 39.9 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 39.9. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Balaxi Pharmaceuticals Ltd

No data available

Company Fundamentals for Balaxi Pharmaceuticals Ltd

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

Share Price

₹ 53.25

0.28 (0.53%)

stock direction

Last updated on: May 08, 2025

Market Price of Balaxi Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Balaxi Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 May 202552.97
06 May 202552.81
05 May 202553.97
02 May 202554.63
30 Apr 202555.16
29 Apr 202556.96
28 Apr 202557.7
25 Apr 202558.37
24 Apr 202560.27
23 Apr 202562.19

SWOT Analysis Of Balaxi Pharmaceuticals Ltd

Strength

4

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Balaxi Pharmaceuticals Ltd

Asset Value vs Market Value of Balaxi Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Balaxi Pharmaceuticals Ltd292.43
Sun Pharmaceutical Industries Ltd427406
Divis Laboratories Ltd163113
Cipla Ltd121869
Torrent Pharmaceuticals Ltd111340
Mankind Pharma Ltd100259

PE Ratio of Balaxi Pharmaceuticals Ltd Explained

292.43

Market cap

27

Earnings

11.1X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Balaxi Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Balaxi Pharmaceuticals Ltd

No data available

* All values are in %

About Balaxi Pharmaceuticals Ltd

  • Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
  • The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017.
  • The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
  • The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

Balaxi Pharmaceuticals Ltd News Hub

Balaxi Pharmaceuticals reports consolidated net profit of Rs 6.48 crore in the June 2024 quarter

Net profit of Balaxi Pharmaceuticals reported to Rs 6.48 crore in the quarter ended June 2024 as aga

Read more

02 Aug 24

Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company will be he

Read more

01 Aug 24

Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter

Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September

Read more

05 Nov 24

Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 20

Read more

30 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Balaxi Pharmaceuticals Ltd

What is the current PE Ratio of Balaxi Pharmaceuticals Ltd?

The Current PE Ratio of Balaxi Pharmaceuticals Ltd is 11.1 as on 8 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 39.9 as on 8 May 2025.

What was the PE Ratio of Balaxi Pharmaceuticals Ltd last year?

The PE Ratio of Balaxi Pharmaceuticals Ltd was 11.75 last year, now the PE ratio is 11.1, showing a year-on-year growth of -5.5%.

What does the PE Ratio of Balaxi Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Balaxi Pharmaceuticals Ltd is 11.1. This ratio indicates that investors are willing to pay 11.1 times the earnings per share for each share of Balaxi Pharmaceuticals Ltd.

What is the PE Ratio Growth of Balaxi Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Balaxi Pharmaceuticals Ltd grew by -5.5% whereas, the EPS ratio grew by 15.5.

How does the PE ratio of Balaxi Pharmaceuticals Ltd compare to industry peers?

The PE ratio of Balaxi Pharmaceuticals Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Balaxi Pharmaceuticals Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Balaxi Pharmaceuticals Ltd PE Ratio.

What factors influence the PE ratio of Balaxi Pharmaceuticals Ltd PE Ratio?

The PE ratio of Balaxi Pharmaceuticals Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Balaxi Pharmaceuticals Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Balaxi Pharmaceuticals Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Balaxi Pharmaceuticals Ltd PE Ratio?

You can check the latest PE ratio of Balaxi Pharmaceuticals Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Balaxi Pharmaceuticals Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Balaxi Pharmaceuticals Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Balaxi Pharmaceuticals Ltd PE Ratio predict future stock performance?

While the Balaxi Pharmaceuticals Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions